NT5DC1 inhibitors represent a specialized class of chemical compounds that target the activity of the NT5DC1 enzyme, a member of the 5'-nucleotidase (NT) family. NT5DC1, or 5'-nucleotidase domain-containing protein 1, plays a role in regulating intracellular nucleotide levels by catalyzing the dephosphorylation of nucleotide monophosphates to nucleosides. Inhibition of NT5DC1 leads to the accumulation of nucleotide monophosphates within cells, thereby influencing the overall balance of nucleotide pools. This enzyme is implicated in a variety of metabolic pathways, particularly those related to purine and pyrimidine metabolism, which are essential for DNA and RNA synthesis, as well as for energy transfer processes within the cell.
Chemically, NT5DC1 inhibitors are structurally diverse and have been developed through the exploration of various chemical scaffolds. These inhibitors typically work by binding to the active site of NT5DC1, blocking the enzyme's ability to catalyze its reaction. The specificity and binding affinity of these inhibitors can be fine-tuned by modifying the chemical groups surrounding the core scaffold, leading to variations in efficacy and selectivity. Detailed structural analyses, such as X-ray crystallography or molecular docking studies, have been utilized to understand the interactions between NT5DC1 and its inhibitors. These studies also provide insights into how modifications in the chemical structure of the inhibitors affect their binding modes and inhibitory potency, offering opportunities for further refinement of these compounds in future chemical development efforts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Known to inhibit nucleoside transport and also has effects on nucleotidase activity, potentially affecting NT5DC1. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Affects purine nucleotide synthesis, potentially influencing the metabolic context of NT5DC1. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
An IMPDH inhibitor, affects purine metabolism, and might indirectly influence NT5DC1's role. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
A xanthine oxidase inhibitor, affects purine catabolism, potentially altering the substrate availability for NT5DC1. | ||||||
Febuxostat | 144060-53-7 | sc-207680 | 10 mg | $168.00 | 3 | |
Another xanthine oxidase inhibitor, could indirectly impact NT5DC1 activity by altering purine metabolism. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase; while primarily affecting pyrimidine synthesis, it could influence nucleotide pools relevant to NT5DC1. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $72.00 $104.00 | ||
A purine analog that inhibits several enzymes in purine synthesis, potentially affecting pathways involving NT5DC1. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
Similar to 6-Mercaptopurine, affects purine metabolism, and could indirectly impact NT5DC1. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Impacts purine metabolism, potentially influencing NT5DC1's function. | ||||||